Moderna
MRNA
MRNA
159 hedge funds and large institutions have $3.41B invested in Moderna in 2019 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 68 increasing their positions, 34 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
27% more capital invested
Capital invested by funds: $2.68B → $3.41B (+$723M)
17% more funds holding
Funds holding: 136 → 159 (+23)
1.21% more ownership
Funds ownership: 51.06% → 52.27% (+1.2%)
Holders
159
Holding in Top 10
6
Calls
$24.3M
Puts
$9.97M
Top Buyers
| 1 | +$71.4M | |
| 2 | +$66M | |
| 3 | +$63.7M | |
| 4 |
SCM
Segantii Capital Management
Hong Kong
|
+$21.4M |
| 5 |
TP
Theleme Partners
London,
United Kingdom
|
+$16.2M |
Top Sellers
| 1 | -$155M | |
| 2 | -$26.5M | |
| 3 | -$16.8M | |
| 4 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$15.6M |
| 5 |
FT
Fiduciary Trust
Boston,
Massachusetts
|
-$7.82M |